Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

GDRX GoodRx Holdings Inc

4,51

0,07 (1,58%)

Zuletzt aktualisiert: 21:12:38

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

GoodRx (NASDAQ:GDRX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more GoodRx Charts.

GoodRx (NASDAQ:GDRX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more GoodRx Charts.

News GoodRx Holdings Inc

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Mittwoch 18 Dezember 2024 (5 Tage vor) • Edgar (US Regulatory)

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Mittwoch 18 Dezember 2024 (5 Tage vor) • Business Wire

GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
Dienstag 17 Dezember 2024 (6 Tage vor) • Business Wire

Form 8-K - Current report
Montag 16 Dezember 2024 (7 Tage vor) • Edgar (US Regulatory)

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
Montag 16 Dezember 2024 (7 Tage vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 10 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 10 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
Donnerstag 5 Dezember 2024 (3 Wochen vor) • Business Wire

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm
Mittwoch 13 November 2024 (1 Monat vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

GoodRx Reports Third Quarter 2024 Results
Donnerstag 7 November 2024 (2 Monate vor) • Business Wire

Weitere GoodRx Holdings Inc News-Artikel

Euro vs Sterling

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen